Published on
Jun 13, 2025
GLP-1 Update: Court Backs FDA in Tirzepatide Compounding Case
On May 7, 2025, the US District Court for the Northern District of Texas upheld the US Food and Drug Administration’s (FDA’s) decision to remove two tirzepatide injection medications from the FDA’s drug shortage list. This ruling will limit most …
Source:
JD Supra - California
-
Neutral
